Tsutsui H, Sakamaki H, Momomura SI, Sakata Y, et al. Cost-effectiveness analysis of Empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-reduced trial. J Cardiol 2023 Feb 27:S0914-5087(23)00046-1. doi: 10.1016/j.jjcc.2023.
PMID: 36858174